Frequency and molecular basis of CD36 deficiency among platelet donors in Kunming, China

References

• Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med. 2014;46(6):e99. doi:10.1038/emm.2014.38.
   PubMed Web of Science ®Google Scholar
• Armesilla AL, Vega MA. Structural organization of the gene for human CD36 glycoprotein. J Biol Chem. 1994;269(29):18985–8. doi:10.1016/S0021-9258(17)32263-9.
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Nagao N, Kanakura Y, Kurata Y, Matsuzawa Y. Family studies of type II CD36 deficient subjects: linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency. Thromb Haemost. 1995;74(02):758–763. doi:10.1055/s-0038-1649809.
   PubMedGoogle Scholar
• Xia W, Xu X, Fu Y, Ye X, Tsuno N, Santoso S. CD36 deficiency among South-East Asian populations. ISBT Sci Ser. 2016;11(S2):33–36. doi:10.1111/voxs.12261.
   Google Scholar
• Lee K, Godeau B, Fromont P, Plonquet A, Debili N, Bachir D, Reviron D, Gourin J, Fernandez E, Galacteros F, et al. CD36 deficiency is frequent and can cause platelet immunization in Africans. Transfusion. 1999;39(8):873–879. doi:10.1046/j.1537-2995.1999.39080873.x.
   PubMed Web of Science ®Google Scholar
• Curtis BR, Aster RH. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion. 1996;36(4):331–334. doi:10.1046/j.1537-2995.1996.36496226147.x.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekiguchi S. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang. 1989;57(3):213–217. doi:10.1111/j.1423-0410.1989.tb00826.x.
   PubMed Web of Science ®Google Scholar
• Yanai H, Chiba H, Fujiwara H, Morimoto M, Abe K, Yoshida S, Takahashi Y, Fuda H, Hui S-P, Akita H, et al. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost. 2000;84(09):436–441. doi:10.1055/s-0037-1614041.
   PubMedGoogle Scholar
• Phuangtham R, Santoso S, Leelayuwat C, Komvilaisak P, Ding H, Romphruk AV. Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma. Transfusion. 2020;60(4):847–854. doi:10.1111/trf.15737.
   PubMed Web of Science ®Google Scholar
• Li R, Qiao Z, Ling B, Lu P, Zhu Z. Incidence and molecular basis of CD36 deficiency in Shanghai population. Transfusion. 2015;55(3):666–673. doi:10.1111/trf.12890.
   PubMed Web of Science ®Google Scholar
• Liu J, Shao Y, Ding H, Deng J, Xu X, Wang J, Xia W, Santoso S, Ye X, Fu Y. Distribution of CD36 deficiency in different Chinese ethnic groups. Hum Immunol. 2020;81(7):366–371. doi:10.1016/j.humimm.2020.05.004.
   PubMed Web of Science ®Google Scholar
• Lo SC, Lin KH, Hsieh HH, Lin D-T, Hu C-Y. Genetic variations of CD36 and low platelet CD36 expression - a risk factor for lipemic plasma donation in Taiwanese apheresis donors. Vox Sang. 2016;110(3):236–243. doi:10.1111/vox.12356.
   PubMed Web of Science ®Google Scholar
• Xu X, Liu Y, Hong X, Chen S, Ma K, Lan X, Ying Y, He J, Zhu F, Lv H. Variants of CD36 gene and their association with CD36 protein expression in platelets. Blood transfusion = Trasfusione del sangue. 2014;12(4):557–564. doi:10.2450/2014.0209-13.
   PubMed Web of Science ®Google Scholar
• Xu X, Ye X, Xia W, Liu J, Ding H, Deng J, Chen Y, Shao Y, Wang J, Fu Y, et al. Studies on CD36 deficiency in South China: two cases demonstrating the clinical impact of anti-CD36 antibodies. Thromb Haemost. 2013;110(12):1199–1206. doi:10.1160/TH13-05-0435.
   PubMedGoogle Scholar
• Lin FQ, Li XF, Li WW, Zhou Z-R, Li J-P. A string of 12 mutations in Intron 3 is a new clue associated with Type II CD36 deficiency. Transfusion. 2019;59(3):1159–1161. doi:10.1111/trf.15084.
   PubMed Web of Science ®Google Scholar
• Bierling P, Godeau B, Fromont P, Bettaieb A, Debili N, el-Kassar N, Rouby JJ, Vainchenker W, Duedari N. Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization. Transfusion. 1995;35(9):777–782. doi:10.1046/j.1537-2995.1995.35996029165.x.
   PubMed Web of Science ®Google Scholar
• Fujino H, Ohta K, Taniue J, Nagao N, Hino M, Yamane T, Koh K-R, Takeoka Y, Hirose A, Aoyama Y, et al. Primary refractoriness to platelet transfusion caused by Nak a antibody alone. Vox Sang. 2001;81(1):42–44. doi:10.1046/j.1423-0410.2001.00048.x.
   PubMed Web of Science ®Google Scholar
• Xia W, Ye X, Xu X, Ding H, Liu J, Deng J, Chen Y, Shao Y, Wang J, Li H, et al. Two cases of platelet transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China. Transfus Med. 2014;24(4):254–256. doi:10.1111/tme.12137.
   PubMed Web of Science ®Google Scholar
• Nakajima F, Nishimura M, Hashimoto S, Okazaki H, Tadokoro K. Role of anti-Nak a antibody, monocytes and platelets in the development of transfusion-related acute lung injury. Vox Sang. 2008;95(4):318–323. doi:10.1111/j.1423-0410.2008.01095.x.
   PubMed Web of Science ®Google Scholar
• Wu G, Zhou Y, Li L, Zhong Z, Li H, Li H, Yu M, Shen W, Ni H. Platelet immunology in China: research and clinical applications. Transfus Med Rev. 2017;31(2):118–125. doi:10.1016/j.tmrv.2016.12.001.
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information. PubChem patent summary for CN-108660198-A. [accessed 2019 Sep 30]. https://pubchem.ncbi.nlm.nih.gov/patent/CN-108660198-A.
   Google Scholar
• Kashiwagi H, Tomiyama Y, Nozaki S, Kiyoi T, Tadokoro S, Matsumoto K, Honda S, Kosugi S, Kurata Y, Matsuzawa Y. Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum Genet. 2001;108(6):459–466. doi:10.1007/s004390100525.
   PubMed Web of Science ®Google Scholar
• Masuda Y, Tamura S, Matsuno K, Nagasawa A, Hayasaka K, Shimizu C, Moriyama T. Diverse CD36 expression among Japanese population: defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects. Thromb Res. 2015;135(5):951–957. doi:10.1016/j.thromres.2015.03.002.
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y. Molecular basis of CD36 deficiency. Evidence that a 478C-->t substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest. 1995;95(3):1040–1046. doi:10.1172/JCI117749.
   PubMed Web of Science ®Google Scholar
• Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med. 2003;13(4):136–141. doi:10.1016/S1050-1738(03)00026-4.
   PubMed Web of Science ®Google Scholar